Optimal Selection of Raw Materials for Pharmaceutical Drug Product Design and Manufacture using Mixed Integer Nonlinear Programming and Multivariate Latent Variable Regression Models
Author:
Affiliation:
1. Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States
2. Pfizer Global Manufacturing,Vega Baja, 00693, Puerto Rico
Publisher
American Chemical Society (ACS)
Subject
Industrial and Manufacturing Engineering,General Chemical Engineering,General Chemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/ie3031828
Reference35 articles.
1. Particle engineering: A strategy for establishing drug substance physical property specifications during small molecule development
2. Improving the prediction of exceptionally poor tableting performance: An investigation into Hiestand's “special case”
3. Development of a high drug load tablet formulation based on assessment of powder manufacturability: Moving towards quality by design
4. Multi-scale pharmaceutical process understanding: From particle to powder to dosage form
5. Improved Protocol and Data Analysis for Accelerated Shelf-Life Estimation of Solid Dosage Forms
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Improving profitability of continuous processes facing raw material variability through data-driven SMB-PLS model-based adaptive control;Computers & Chemical Engineering;2024-05
2. Adjusting plant operating conditions to widen multivariate specification regions for incoming raw materials – An optimization framework;Chemometrics and Intelligent Laboratory Systems;2024-01
3. A Rational Hierarchy to Capture Raw Material Attribute Variability in the Pharmaceutical Drug Product Development and Manufacturing Lifecycle;Journal of Pharmaceutical Sciences;2023-10
4. Defining multivariate raw material specifications in industry 4.0;Chemometrics and Intelligent Laboratory Systems;2022-06
5. Use of machine learning in prediction of granule particle size distribution and tablet tensile strength in commercial pharmaceutical manufacturing;International Journal of Pharmaceutics;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3